Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric Complications
Clive E. Hyde, Graham Glancy, P. Omerod, David E. Hall, Gary Taylor
The British Journal of Psychiatry June 1, 1978 DOI: 10.1192/bjp.132.6.602 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Sample size | 3 |
| Population | Patients presenting to medical or psychiatric emergency clinics after using Psilocybe semilanceata |
| Intervention | Psilocybe semilanceata |
| Topics | Psilocybin |
| Keywords | Indigenous Hallucinogen Schizophrenia object-oriented programming Mushroom poisoning Medical emergency Poison control |
| Citations | 47 |
| Key findings | Use of Psilocybe semilanceata can cause typical psychedelic effects, transient psychosis, and prolonged schizophrenia-like states, with sympathomimetic signs in some cases. |
Abstract
Summary The use for hallucinogenic purposes of an indigenous mushroom, Psilocybe semilanceata indigenous to Britain is reported in three patients. Typical psychedelic, transient psychotic and more prolonged schizophrenia-like states were seen, with sympathomimetic signs noted in two cases, in one being prolonged. Enquiry about such mushroom abuse should be considered in individuals presenting to medical or psychiatric emergency clinics.
Comparable studies
Other case reports and case series on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction 18-year-old man | 1998 | Case study | n = 1 |
| Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) Person with leg amputation and phantom-limb pain | 2018 | Case study | n = 1 |
| Hallucinogen persisting perception disorder after psilocybin consumption: a case study 18-year-old man with HPPD after mixed psilocybin and cannabis intoxication | 2005 | Case study | n = 1 |
| Microdosing psilocybin for chronic pain: a case series Individuals with chronic neuropathic pain | 2022 | Case series | n = 3 |
| Psilocybin and Obsessive Compulsive Disorder Individual with Obsessive Compulsive Disorder | 2014 | Case study | n = 1 |
Citations in the library
Cited by 23
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
- Drug models of schizophrenia. Therapeutic Advances in Psychopharmacology February 1, 2015
- Clinical toxicology of ‘magic mushroom’ ingestion Postgraduate Medical Journal September 1, 1981
- Hallucinogenic Mushrooms Clinical Pediatrics February 1, 1988
and 18 more in the library